![Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease | Circulation Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease | Circulation](https://www.ahajournals.org/cms/asset/81c4ca46-0d44-4ad7-85ba-e7bee411ae19/1481fig01.jpg)
Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease | Circulation
![Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia | Circulation Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia | Circulation](https://www.ahajournals.org/cms/asset/b8130571-0b3b-4434-9389-d51f2a81809c/234fig02.jpeg)
Efficacy and Safety of Longer-Term Administration of Evolocumab (AMG 145) in Patients With Hypercholesterolemia | Circulation
![(PDF) Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: A randomized, double-blind, placebo-controlled trial (PDF) Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: A randomized, double-blind, placebo-controlled trial](https://i1.rgstatic.net/publication/320720992_Vitamin_D3_repletion_versus_placebo_as_adjunctive_treatment_of_heart_failure_patient_quality_of_life_and_hormonal_indices_A_randomized_double-blind_placebo-controlled_trial/links/59f7fe41a6fdcc075ec7c919/largepreview.png)